Dev Labtech Venture Limited has completed its initial investment in the Dubai-based wholly-owned subsidiary DEV LABTECH TRADING FZCO, marking a significant step in the company's international expansion strategy. The company made a payment of AED 4,90,000 on March 13, 2026, with confirmation of receipt received on March 14, 2026.

Investment Details

The subscription involves 490 equity shares at AED 1,000 each par value, representing 100% shareholding in the subsidiary. The investment was made entirely through cash consideration, with the company fully subscribing to the share capital of the newly incorporated entity.

Subsidiary Company Profile

DEV LABTECH TRADING FZCO was incorporated on October 29, 2025, in Dubai, UAE, under Certificate of Registration No. DMCC203584 issued by The Registrar of Companies of the Dubai Multi Commodities Centre Authority (DMCCA). The subsidiary operates in the trading of jewellery, diamonds, pearls and precious stones, aligning with the parent company's core business activities.

Strategic Objectives

The acquisition serves multiple strategic purposes for Dev Labtech Venture Limited. The company aims to expand its business operations and establish a global presence while leveraging new growth opportunities in the UAE markets. As a newly incorporated entity, the subsidiary currently has no operational history or turnover.

Regulatory Compliance

The investment constitutes a related party transaction as DEV LABTECH TRADING FZCO is a wholly-owned subsidiary. The company has confirmed that the investment is conducted on an arm's length basis. No specific regulatory approvals were required for this acquisition, as the entity was incorporated pursuant to relevant UAE laws and statutes.

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing comprehensive details of the investment to BSE Limited where its shares are listed on the SME platform.

Dev Labtech Venture Limited announced that its Board of Directors has approved the strike-off of its wholly owned US subsidiary during their meeting held on January 22, 2026. The decision involves Dev Labtech Venture Inc. (USA), which had remained non-operational since its incorporation.

Board Resolution Details

The company's board meeting on January 22, 2026, formally approved the strike-off of Dev Labtech Venture Inc. (USA), subject to approval from relevant regulatory authorities in the United States. This corporate action has been communicated to BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Subsidiary Performance Overview

The US subsidiary's financial contribution to the parent company has been minimal, as detailed in the regulatory disclosure:

Regulatory Compliance

Dev Labtech Venture Limited has fulfilled its disclosure obligations under SEBI regulations by providing comprehensive details about the subsidiary strike-off. The company submitted the required information as per Regulation 30 and Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Timeline and Process

The strike-off process is anticipated to take approximately 4 to 5 months, contingent upon receiving necessary approvals from US regulatory authorities. Since Dev Labtech Venture Inc. had no active business operations, the strike-off represents a streamlining of the company's corporate structure rather than a disposal of active business assets.

Corporate Structure Impact

This development will result in the elimination of a non-contributing subsidiary from Dev Labtech Venture Limited's corporate structure. The strike-off will have no material impact on the company's operations or financial performance, given the subsidiary's dormant status since incorporation.